180340-69-6

Usage

Uses

Used in Pharmaceutical Industry:
6-Amino-5-bromonicotinic acid is used as a building block for the synthesis of pharmaceutical drugs, leveraging its chemical structure to create new medicinal compounds with potential therapeutic effects.
Used in Chemical Industry:
It serves as a precursor for the production of other organic compounds, contributing to the development of novel chemical entities for various applications.
Used in Agrochemical Production:
6-Amino-5-bromonicotinic acid is used as an intermediate in the preparation of agrochemicals, playing a crucial role in the synthesis of substances that can enhance crop protection and yield.
Used in Dye Manufacturing:
6-AMINO-5-BROMONICOTINIC ACID is utilized in the creation of dyes, capitalizing on its chemical properties to produce colorants for various industrial applications.
Used in Biological Research:
6-Amino-5-bromonicotinic acid may have biological activities and is studied for its potential pharmacological properties, opening avenues for research into new treatments and therapies.

InChI:InChI=1/C6H5BrN2O2/c7-4-1-3(6(10)11)2-9-5(4)8/h1-2H,(H2,8,9)(H,10,11)

Upstream product

• 3167-49-5 6-aminonicotinic acid 
• 850429-51-5 6-amino-5-bromonicotinic acid ethyl ester 
• 180340-70-9 methyl 6-amino-5-bromopyridine-3-carboxylate 

Downstream Products

• 180340-70-9 methyl 6-amino-5-bromopyridine-3-carboxylate 

Relevant academic research and scientific papers

FURTHER HETEROAROMATIC COMPOUNDS HAVING ACTIVITY AGAINST RSV

The invention concerns compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising thes

AZACARBOLINE DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME

The invention relates to novel azacarbonlines having formula (I), wherein: R3, R4 represent independently H; hal; CF3; substituted oxy, optionally substituted alkoxy; optionally substituted amino; substituted carbonyl; optionally substituted carboxyl; optionally substituted amide; sulphur, such as optionally substituted sulphones, sulphoxides or sulphides; linear, branched or cyclic C1-C10 alkyl optionally comprising an optionally substituted heteroatom; optionally substituted linear, branched or cyclic C2-C7 alkenyl; optionally substituted linear or branched C2-C6 alkynyl; optionally substituted aryl or heteroaryl; of which may be optionally substituted; in the form of a base or an acid addition salt. The invention also relates to the use of same in therapeutics for the treatment of cancer and to synthesis methods.

Pyrazine derivatives as modulators of tyrosine kinases

The present invention provides pyrazine derivatives that inhibit tyrosine kinase activity. Certain pyrazine derivatives are selective inhibitors of vascular endothelial growth factor (VEGF) receptor tyrosine kinase. The present invention also provides pharmaceutical formulations containing the pyrazine derivatives and methods of use of these formulations as anti-tumor agents and to treat solid-tumor cancers, angiogenesis, diabetic retinopathy, rheumatoid arthritis, endometriosis and psoriasis.

TRICYCLIC THIENO-AZEPINE VASOPRESSIN ANTAGONISTS

This invention relates to new bicyclic non-peptide vasopressin antagonists which are useful in treating conditions where decreased vasopressin levels are desired, such as in congestive heart failure, in disease conditions with excess renal water reabsorption and in conditions with increased vascular resistance and coronary vasoconstriction.